Validation criteria and the samples used | Samples [N] | Assays [n] | Results | ||
---|---|---|---|---|---|
Analytical specificity (Asp) | True negative | False positive | Asp (%) | ||
TN | FP | TN/(TN + FP) | |||
Reference antisera against non-H5 subtype LPAIVs | 22 | 43 | 43 | 0 | 100 |
Diagnostic specificity (Dsp) | True negative | False positive | Dsp [%] | ||
TN | FP | TN/(TN + FP) | |||
Various-origin sera negative against H5 HA | 209 | 209 | 204 | 5a | 97.6 |
Diagnostic sensitivity (Dse) 1 | True positive | False negative | Dse 1 (%) | ||
TP | FN | TP/(TP + FN) | |||
Reference antisera against H5-subtype LPAIVs | 9 | 99 | 97 | 2b | 98.0 |
Diagnostic sensitivity (Dse) 2 | True positive | False negative | Dse 2 (%) | ||
TP | FN | TP/(TP + FN) | |||
Experimental antisera against HA from H5N1 HPAIV | 115 | 115 | 114 | 1c | 99.1 |
Repeatability of assays | Mean [OD450] | SDd | RSDe (%) | ||
G-7-27-18 mAb control | 1 | 13 | 1.566 | 0.111 | 7.1 |
Normal chicken serum (negative control) | 1 | 13 | 1.460 | 0.114 | 7.8 |
Anti-H5N2 LPAIV antiserum (weak positive control) | 1 | 12 | 0.944 | 0.083 | 8.8 |
Anti-H5N3 LPAIV antiserum (strong positive control) | 1 | 12 | 0.439 | 0.044 | 10.0 |